Table: RaQualia Pharma -2024 group results

RaQualia Pharma

14/02/2025 06:45

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT   
              Dec 31, 2024    Dec 31, 2023    Dec 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           3.11            1.90            3.89                  
               (+63.5 pct)     (-34.8 pct)    (+25.1 pct)               
  Operating   loss 213 mln    loss 337 mln      118 mln                 
  Recurring   loss 361 mln    loss 293 mln       73 mln                 
  Net
  Net         loss 495 mln    loss 323 mln    loss 71 mln               
  EPS        loss 22.87 yen  loss 14.98 yen  loss 3.25 yen              
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T